Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002408044 | SCV002722509 | uncertain significance | Inborn genetic diseases | 2021-07-23 | criteria provided, single submitter | clinical testing | The c.1892-6C>T intronic variant results from a C to T substitution 6 nucleotides upstream from coding exon 10 in the SPG11 gene. This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003097330 | SCV003251611 | likely benign | Hereditary spastic paraplegia 11 | 2023-10-17 | criteria provided, single submitter | clinical testing |